Evidence map›Paper›PMID 36937029›Full record

ArticleJAAD international2023

Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab.

Francesco Bellinato, Giovanni Adami, Antonio Furci, Giorgio Cattani, Donatella Schena, Giampiero Girolomoni, Paolo Gisondi

Open access · goldAbstract read
In one paragraph

Article in JAAD international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Impact of particulate matter exposure on melanoma risk: A multicentre case-control study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2025
    Observational
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Francesco BellinatoSection of Dermatology and Venereology.
Giovanni AdamiSection of Rheumatology, Department of Medicine, University of Verona, Verona, Italy.
Antonio FurciSection of Dermatology and Venereology.
Giorgio CattaniItalian Institute for Environmental Protection and Research, Rome, Italy.
Donatella SchenaSection of Dermatology and Venereology.
Giampiero GirolomoniSection of Dermatology and Venereology.
Paolo GisondiSection of Dermatology and Venereology.
Austrian Society of Dermatology and Venereology · ATIstituto Superiore per la Protezione e la Ricerca Ambientale · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The magnitude of short/medium-term air pollution exposure on atopic dermatitis (AD) flare has not been fully investigated. The aim of the study was to investigate the association of short/medium-term exposure to airborne pollution on AD flares in patients treated with dupilumab. Methods: Observational case-crossover study. Patients with moderate-to-severe AD under treatment with dupilumab were included. The exposure of interest was the mean concentrations of coarse and fine particulate matter (PM Results: Data on 169 of 528 patients with AD having 1130 follow-up visits and 5840 air pollutant concentration measurements were retrieved. The mean age was 41.4 ± 20.3 years; 94 (55%) men. The incremental odds curve indicated a significant positive trend of AD flare for all pollutants in all time windows. At 60 days, every 10 μg/m Conclusions: In patients treated with dupilumab

Indexed as

AD, atopic dermatitisAir pollutionatopic dermatitisCO, carbon monoxidedupilumabEASI, Eczema Area and Severity IndexflareIQR, interquartile rangeNO2, nitrogen dioxideNO, nitrogen monoxideNOx, oxides of nitrogenparticulate matterPM, particulate matterSO2, sulfur dioxide

Identifiers

PMID36937029
PMCPMC10020116
OpenAlexW4319870699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.